menu
    • menu

    Company profile for AN2 Therapeutics

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to develop therapeutics to treat rare, chronic, and serious infectious diseases in areas of high unmet medical need. As leaders in the field of antimicrobials, we also have both an obligation and a strong desire to combine our drug discovery and development expertise with resources available from public and private organizations to address high unmet needs in global health.AN2 Therapeutics, Inc. is a biopharmace...
    Our mission is to develop therapeutics to treat rare, chronic, and serious infectious diseases in areas of high unmet medical need. As leaders in the field of antimicrobials, we also have both an obligation and a strong desire to combine our drug discovery and development expertise with resources available from public and private organizations to address high unmet needs in global health.AN2 Therapeutics, Inc. is a biopharmaceutical company dedicated to developing therapies to treat rare, chronic, and serious infectious diseases in areas of high unmet needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AN2 TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1800 El Camino Real, Suite D Menlo Park, CA 94027
    Telephone
    Telephone
    650-331-9090
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.an2therapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/an2-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AN2 Starts Ph2 Trial Epetraborole in M. Abscessus Lung Disease
    AN2 Starts Ph2 Trial Epetraborole in M. Abscessus Lung Disease

    31 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260331370403/en/AN2-Therapeutics-Announces-Initiation-of-Phase-2-Investigator-Initiated-Clinical-Trial-of-Epetraborole-for-Mycobacterium-abscessus-Complex-Lung-Disease

    BUSSINESSWIRE
    31 Mar 2026
    Share Share
    AN2 Therapeutics Reports Q4 and FY 2025 Financial Results
    AN2 Therapeutics Reports Q4 and FY 2025 Financial Results

    17 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260317440715/en/AN2-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Recent-Business-and-Scientific-Highlights

    BUSSINESSWIRE
    17 Mar 2026
    Share Share
    AN2 Therapeutics Announces $40 Million Private Placement
    AN2 Therapeutics Announces $40 Million Private Placement

    09 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260309853686/en/AN2-Therapeutics-Announces-%2440-Million-Private-Placement-Financing

    BUSSINESSWIRE
    09 Mar 2026
    Share Share
    AN2 Therapeutics To Progress Oral Epetraborole Into Phase 2
    AN2 Therapeutics To Progress Oral Epetraborole Into Phase 2

    03 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260303819156/en/AN2-Therapeutics-Announces-Plans-to-Advance-Oral-Epetraborole-into-Phase-2-Study-for-Polycythemia-Vera-PV

    BUSINESSWIRE
    03 Mar 2026
    Share Share
    AN2 Therapeutics Joins Chat at Leerink Healthcare Conference
    AN2 Therapeutics Joins Chat at Leerink Healthcare Conference

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217634495/en/AN2-Therapeutics-to-Participate-in-Fireside-Chat-at-Leerink-Global-Healthcare-Conference

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    AN2 Therapeutics To Launch 90-Patient Trial For Epetraborole
    AN2 Therapeutics To Launch 90-Patient Trial For Epetraborole

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112479198/en/AN2-Therapeutics-Announces-FDA-Clearance-to-Proceed-with-90-Patient-Investigator-Initiated-Trial-IIT-of-Epetraborole-in-Patients-with-M.-abscessus-Lung-Disease

    BUSINESSWIRE
    12 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search